BIXT Message Board Post 9523070 | Bioxytran Inc
home / stock / bixt / bixt message board
bellaria876
()
Posted on: May/01/2023 07:01:16
A biotechnology company called Bioxytran, Inc.($BIXT) is in the clinical stages of developing novel therapies with the goal of meeting unmet medical needs in the areas of virology, degenerative diseases, and hypoxia. Prolectin-M, the top drug candidate, belongs to a brand-new class of antiviral medications made to combat galectins linked to inflammatory, fibrotic, and cancerous diseases. The other development projects for bioxytran are for the treatment of stroke and pulmonary fibrosis. There are 123,502,235 shares outstanding.
News, Short Squeeze, Breakout and More Instantly...
-
COPT Defense Properties of Beneficial Interest (CDP) is expected to report $0.64 for Q2 2024 Bank of Marin Bancorp (BMRC) is expected to report $0.19 for Q2 2024 Oak Ridge Financial Services Inc (BKOR) is expected to report for Q2 2024 D/B/A Centerspace (CSR) is expected to report $1....
-
The Heme Foundation and Bioxytran join forces to address the global blood supply shortage BOSTON, MASSACHUSETTS, July 18, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to t...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...